The federal government has expanded its drug price negotiation program for seniors in Michigan and beyond, adding more than a ...

A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a ...

The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The Trump ...